Label: CANTHARIDIN 0.7% liquid
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Updated May 17, 2019
If you are a consumer or patient please visit this version.
- Directions for use
- Sincerus Florida, LLC. Adverse reactions
- Active, inactive
- NDC 72934- 9035-9 CANTHARIDIN 0.7%. Liquid 15 gm
INGREDIENTS AND APPEARANCE
cantharidin 0.7% liquid
Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-9035 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CANTHARIDIN (UNII: IGL471WQ8P) (CANTHARIDIN - UNII:IGL471WQ8P) CANTHARIDIN 0.7 g in 100 g Product Characteristics Color white (clear liquid) Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-9035-9 15 g in 1 VIAL; Type 0: Not a Combination Product 05/17/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/17/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-9035)